Ming-Tain Lai
Department of Antiviral Research
Merck Research Laboratories
770 Sumneytown Pike
West Point
USA
Name/email consistency: high
- Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors. Lai, M.T., Lu, M., Felock, P.J., Hrin, R.C., Wang, Y.J., Yan, Y., Munshi, S., McGaughey, G.B., Tynebor, R.M., Tucker, T.J., Williams, T.M., Grobler, J.A., Hazuda, D.J., McKenna, P.M., Miller, M.D. Antimicrob. Agents Chemother. (2010)
- Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Lai, M.T., Munshi, V., Touch, S., Tynebor, R.M., Tucker, T.J., McKenna, P.M., Williams, T.M., DiStefano, D.J., Hazuda, D.J., Miller, M.D. Antimicrob. Agents Chemother. (2009)
- Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. Lai, M.T., Chen, E., Crouthamel, M.C., DiMuzio-Mower, J., Xu, M., Huang, Q., Price, E., Register, R.B., Shi, X.P., Donoviel, D.B., Bernstein, A., Hazuda, D., Gardell, S.J., Li, Y.M. J. Biol. Chem. (2003)
